NDC - HCPCS Crosswalk

Effective October 1, 2018 through December 31, 2018

The crosswalk is intended to help understand which drug products -identified by NDCs- are assigned to which HCPCS billing codes. The crosswalk is not intended to be a comprehensive list of all NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units.

NDC HCPCS Code Labeler Drug Name Dosage Package Size Package Quantity Billable Units Billable Units / Pkg
62935-452-45J9217TolmarLeuprolide acetate suspnsion7.5 MG1166
62935-453-45J9217TolmarLeuprolide acetate suspnsion7.5 MG1166
62935-752-75J9217TolmarLeuprolide acetate suspnsion7.5 MG1111
62935-753-75J9217TolmarLeuprolide acetate suspnsion7.5 MG1111
0781-4003-32J9218Sandoz, Inc.Leuprolide acetate injeciton1 MG2.811414
47335-936-40J9218Sun Pharmaceutical Global Fze.Leuprolide acetate injeciton1 MG2.811414
67979-500-01J9225Endo Pharmaceuticals Valera Inc.Vantas implant50 MG1111
67979-002-01J9226Endo Pharmaceuticals Valera Inc.Supprelin la implant50 MG1111
0003-2327-11J9228Bristol-Myers Squibb CompanyIpilimumab injection1 MG1015050
0003-2328-22J9228Bristol-Myers Squibb CompanyIpilimumab injection1 MG401200200
55292-911-51J9230Recordati Rare DiseasesMechlorethamine hcl inj10 MG1414
25021-221-60J9245Sagent Pharmaceuticals IncInj melphalan hydrochl 50 mg50 MG1111
42023-149-01J9245Par Pharmaceutical, IncInj melphalan hydrochl 50 mg50 MG1111
43598-392-48J9245Dr. Reddy's Laboratories, Inc.Inj melphalan hydrochl 50 mg50 MG1111
45963-686-02J9245Actavis Pharma, Inc.Inj melphalan hydrochl 50 mg50 MG1111
52609-3001-0J9245ApoPharma USA, Inc.Inj melphalan hydrochl 50 mg50 MG1111
63323-760-20J9245FRESENIUS KABI USAInj melphalan hydrochl 50 mg50 MG1111
67457-195-01J9245Mylan InstitutionalInj melphalan hydrochl 50 mg50 MG1111
67457-215-01J9245Mylan InstitutionalInj melphalan hydrochl 50 mg50 MG1111
67457-579-01J9245Mylan InstitutionalInj melphalan hydrochl 50 mg50 MG1111
68152-109-00J9245Spectrum PharmaceuticalsInj melphalan hydrochl 50 mg50 MG1111
0143-9519-10J9250WEST-WARD PHARMACEUTICAL CORP.Methotrexate sodium inj5 MG21010100
0143-9830-01J9250West-Ward Pharmaceuticals CorpMethotrexate sodium inj5 MG11200200
0703-3671-03J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG21010100
0703-3671-93J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG21010100
0703-3675-01J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG1015050
0703-3675-91J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG1015050
0703-3678-01J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG401200200
0703-3678-81J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG401200200
16729-277-03J9250Accord Healthcare Inc.Methotrexate sodium inj5 MG1015050
16729-277-30J9250Accord Healthcare Inc.Methotrexate sodium inj5 MG211010
16729-277-35J9250Accord Healthcare Inc.Methotrexate sodium inj5 MG401200200
61703-350-10J9250Pfizer Inc.Methotrexate sodium inj5 MG251050
61703-350-38J9250Pfizer Inc.Methotrexate sodium inj5 MG251050
61703-408-41J9250Pfizer Inc.Methotrexate sodium inj5 MG401200200
63323-122-50J9250Fresenius Kabi USA LLCMethotrexate sodium inj5 MG11200200
63323-123-10J9250Fresenius Kabi USA LLCMethotrexate sodium inj5 MG1015050
67457-466-10J9250Mylan InstitutionalMethotrexate sodium inj5 MG1015050
67457-480-40J9250Mylan InstitutionalMethotrexate sodium inj5 MG401200200
0143-9519-10J9260WEST-WARD PHARMACEUTICAL CORP.Methotrexate sodium inj50 MG210110
0143-9830-01J9260West-Ward Pharmaceuticals CorpMethotrexate sodium inj50 MG112020
0703-3671-03J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG210110
0703-3671-93J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG210110
0703-3675-01J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG10155
0703-3675-91J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG10155
0703-3678-01J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG4012020
0703-3678-81J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG4012020
16729-277-03J9260Accord Healthcare Inc.Methotrexate sodium inj50 MG10155
16729-277-30J9260Accord Healthcare Inc.Methotrexate sodium inj50 MG2111
16729-277-35J9260Accord Healthcare Inc.Methotrexate sodium inj50 MG4012020
61703-350-10J9260Pfizer Inc.Methotrexate sodium inj50 MG2515
61703-350-38J9260Pfizer Inc.Methotrexate sodium inj50 MG2515
61703-408-41J9260Pfizer Inc.Methotrexate sodium inj50 MG4012020
63323-122-50J9260Fresenius Kabi USA LLCMethotrexate sodium inj50 MG112020
63323-123-10J9260Fresenius Kabi USA LLCMethotrexate sodium inj50 MG10155
67457-466-10J9260Mylan InstitutionalMethotrexate sodium inj50 MG10155
67457-480-40J9260Mylan InstitutionalMethotrexate sodium inj50 MG4012020
0007-4401-06J9261Novartis Pharmaceuticals CorporationNelarabine injection50 MG506530
0078-0683-06J9261Novartis Pharmaceuticals CorporationNelarabine injection50 MG506530
0703-3985-01J9263Sicor Pharmaceuticals, Inc.Oxaliplatin0.5 MG101100100
Page 60